No, allulose should not replace pharmaceutical GLP-1 receptor agonists prescribed for diabetes
These characteristics help differentiate neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease from MS
Traceability In order to improve the traceability of biological medicinal products, record the name and the lot number (included on the outer cartons and blister) of the medicine you are taking and provide this information when reporting any side effects
Even patients who tolerate GLP-1 treatment just fine dont necessarily enjoy the medications effects
X., Cao, Y., Yu, X., Samuel, R., Ali, B., Desiderio, R., Cholankeril, G., & Bajaj, M